Axa’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-17,797
| Closed | -$2.11M | – | 1238 |
|
|
2021
Q4 | $2.11M | Buy |
17,797
+210
| +1% | +$24.9K | 0.01% | 834 |
|
|
2021
Q3 | $3.5M | Buy |
17,587
+613
| +4% | +$122K | 0.01% | 763 |
|
|
2021
Q2 | $2.95M | Buy |
16,974
+17
| +0.1% | +$2.96K | 0.01% | 809 |
|
|
2021
Q1 | $3.36M | Buy |
16,957
+397
| +2% | +$78.6K | 0.01% | 768 |
|
|
2020
Q4 | $3.26M | Buy |
16,560
+4,355
| +36% | +$857K | 0.01% | 779 |
|
|
2020
Q3 | $2.16M | Buy |
+12,205
| New | +$2.16M | 0.01% | 799 |
|